M. Paige Watt MA BSN RN
Atlanta,GA
Summary
Accomplished oncology medical professional with expertise in Healthcare/Biosciences, Clinical Consulting/Education, Business Development/Marketing, and Law. Proven track record of engaging key opinion leaders through a unique blend of clinical analysis, strategic marketing assessments, and deep scientific knowledge, facilitating impactful discussions on oncology treatments and therapies. Highly intuitive and grounded in ethics, demonstrating an outstanding work ethic, integrity, and an unwavering commitment to excellence with a patient-centric focus. Eager to contribute to a dynamic start-up or established organization that values teamwork and fosters autonomy.
Overview
16
16
years of professional experience
Work History
Oncology Clinical Abstractor
Independent Healthcare Consultant/Oncology Clinical Abstractor
Atlanta, GA
11.2015 - Current
- Achieved compliance with care standards and regulatory guidelines through targeted consultative support for healthcare systems and physician practices. Delivered strategic evaluations on multiple projects, enhancing certification and accreditation processes for hospitals and clinical practices.
- Analyzed and organized large volumes of clinical data and documentation to support legal strategies in significant personal injury and medical malpractice cases.
- Delivered in-depth operational insights into pre-, post-, active, and settlement phases of litigation trials, ensuring effective navigation of federal, state, and supreme court processes.
- Led initiatives to curate structural data elements from clinical notes and reports, effectively mapping key attributes to established data standards. Oversaw projects focused on evaluating the effectiveness of breast cancer treatments across primary, secondary, and tertiary care levels. Championed accreditation processes for JCAHO and HEDIS while driving performance evaluations against quantifiable benchmarks.
- Facilitated timely access to information, enhancing project efficiency. Delivered comprehensive abstracting services at Flatiron Health and E-Code Solutions. Achieved successful HEDIS outcomes with The Broadwell Group. Drove impactful consulting solutions at Dig Worldwide. Contributed to legal case preparations at The Stone Law Firm, Nall & Miller, and Greenberg Traurig Law. Enhanced healthcare consulting at Intermountain Healthcare as an Optimum Consultant. Elevated peer review standards at Optum Insight. Advanced oncology clinical abstraction initiatives with McKesson.
- Spearheaded initiatives to optimize workflow and enhance efficiency in project deliverables.
- Synthesized abstracted data analyses to inform and support clinical strategies and research initiatives.
Clinical Oncology Abstractor
Flatiron Health, Inc.
Atlanta, GA
02.2023 - 09.2024
- Advanced research efforts utilizing real-world data to provide insights into challenging oncologic diagnoses.
- Conducted in-depth analysis and synthesis of clinical records to optimize patient experiences and health outcomes.
- Analyzed and organized de-identified unstructured data, extracting critical insights to support the validity of clinical study documentation.
- Certified specialist in areas with comprehensive knowledge of Non-Small Cell Lung Cancer/Small Cell Lung Cancer and treatment; Diffuse Large B Cell Lymphoma and treatment; Follicular Lymphoma and treatment; Multiple Myeloma and treatment; Mantle Cell Lymphoma and treatment; Non-Hodgkins Lymphoma and treatment; Breast Cancer and treatment; Acute Myeloid Leukemia and treatment; Colorectal Cancer and treatment; Biliary Tract Cancers and treatment; Universal sites of metastatic cancer; IV systemic treatment for various medications for solid tumors (breast, colorectal, endometrial, melanoma, hepatic, and renal) as well as for those for hematologic cancers.
- Certification specialist with extensive knowledge of biomarker testing: Next Generation Sequencing, IHC, PCR, FISH, DNA and RNA sequencing, liquid and tissue biopsies, companion and reflexive diagnostics, mass spectrometry, and proteomics. Includes interpretation of results of Programmed Death Ligands (PD-L1) biomarkers; HER-2/ERBB2 biomarkers; MET, RET, NTRK, EGFR, KRAS, ROS1 biomarkers for NSCLC.
- Adept at the interpretation of germline and somatic biomarker testing, including results for Caris Life Sciences, Foundation Medicine, Guardant, Integrated Oncology/Labcorp, NeoGenomics, Quest Diagnostics, Myriad, Tempus, Ambrey Genetics, Invitae, Quest, bioTheranostics, University of Penn Pathology, Yale Pathology, Moffit analysis, Memorial Sloan Kettering (MSK Impact), MD Anderson, Fox Chase Cancer Center, Mass General, and Mayo Clinic Labs.
Clinical Science Liaison (CSL)
InterVenn Biosciences
Remote, Entire U.S. As Territory
01.2022 - 06.2022
- Hired as the inaugural CSL with an international biotech start-up company, operating as a privately held company focused on interrogating the glycoproteome for developing new clinical insights, biomarkers, therapeutics, and diagnostics across several disease indications, including those of numerous cancer tumor sites.
- Educated on glycoproteomics as a clinical layer of biology beyond the genome and its recognition for its potential role in disease processes such as cancer. Adept at providing expert knowledge of InterVenn’s methodology of utilizing a simple blood draw or a liquid biopsy and their patented development of an A.I.-enabled software platform that can work with mass spectrometry to create high throughput automated analysis solutions to understand and interpret these illnesses.
- Collaborated with international academic and community [oncology] research sites participating in clinical studies. Responsible for evaluating site feasibility, qualification, initiation of places to begin studies, and monitoring throughout the study and until the end of the trial.
- Led initiatives to foster relationships with oncology KOLs and HCPs, representing the chief medical officer and clinical affairs team. Drove strategic advancements in medical communications to improve healthcare outcomes. Coordinated with internal stakeholders to ensure project success.
- Customized work instructions and standard operating procedures to facilitate effective training and support for new clinical science liaisons.
- Led initiatives to facilitate the submission of 100+ scientific and clinical publications to prestigious trade journals and international conferences such as ASCO and ESCO. Authored and published an original white paper to enhance industry knowledge.
Oncology Nurse Educator, Keytruda (pembrolizumab) Immunotherapy
McKesson/Merck
Southeastern Territory, U.S.A.
08.2019 - 07.2021
- Achieved effective dissemination of scientific data within the medical oncology community by representing Keytruda (pembrolizumab) at numerous conferences for 28+ solid and blood tumor indications. Contributed to knowledge on precision medicine, immune-mediated adverse events, targeted therapies, and immunotherapy.
- Led cross-functional presentations involving marketing, medical affairs, and pathology representatives to effectively communicate efficacy and safety data from multiple clinical trials to KOLs and healthcare business professionals. Fostered a culture of knowledge sharing among team and field colleagues to enhance overall expertise.
- Contributed to the formulation of a national initiative focused on improving awareness of immune-mediated adverse events in emergency room departments and ICUs, in accordance with NCCN guidelines.
- Delivered comprehensive knowledge of clinical research disease processes and advanced oncology care best practices to enhance education at academic institutions, community hospitals, and nursing forums regionally and nationally.
- Achieved exceptional engagement outcomes through effective management of virtual and live educational sessions. Surpassed performance goals, establishing a reputation as a top performer among nurse educators nationwide.
Clinical Nurse Educator (BD Vascular Devices)
Novasyte, LLC
Atlanta, GA
10.2018 - 09.2019
- Collaborated with healthcare facilities to provide expert clinical support and educational resources for Becton Dickinson/Bard vascular devices.
- Executed strategic initiatives to enhance operational efficiency at IQVIA.
Associate Content Editor (Lung Cancer)
American Cancer Society
07.2018 - 02.2019
- Analyzed and consolidated clinical information from ASCO and additional resources to enhance content quality on cancer.org website.
Oncology Nurse Educator/Medical Sciences Liaison
Heron Therapeutics
Eastern Territory, USA
06.2017 - 01.2018
- Cultivated partnerships and fostered scientific dialogue with community and academic cancer centers throughout eastern region to enhance collaborative research efforts.
- Interacted with oncology HCPs and KOLs, providing clinical data while collaborating with field sales/marketing teams. Competent in several CRM programs.
- Executed successful launch of innovative, patented medications by educating healthcare professionals on unique polymer delivery system and its pathogenesis to enhance patient outcomes.
- Led initiatives to deepen knowledge of therapeutic disease states and clinical trial strategies for product launches. Oversaw preparations for a third medication in the expedited pipeline scheduled for fall 2018 release.
- Achieved effective product representation at conferences and seminars, enhancing awareness of biopharmaceutical offerings. Drove the successful management and implementation of Heron products, aligning with industry regulations and operational guidelines.
- Collaborated with oncology nurses to enhance participation in key advisory board sessions focused on NK1 and 5HT3 receptor antagonist products.
Clinical Oncology/Scientific Exchange Analyst
Axess Oncology
Atlanta, GA
05.2016 - 10.2016
- Pioneered clinical initiatives as inaugural clinician for international oncology start-up, driving development of proprietary oncologists' network.
- Orchestrated discussions among oncologists and pharmaceutical representatives to uncover insights and improve collaborative communication efforts.
- Forged professional relationships with national, regional, and local key opinion leaders in the national oncology community in academic and underserved cancer practices.
- Spearheaded the creation of a national oncology nurses’ and pharmacologists’ network, focused on developing integrated communication in the specialty of oncology practice.
Oncology Nurse Navigator/Educator (GI/GU, Prostate and Solid, and hematologic tumors)
Wellstar North Fulton Hospital
02.2014 - 03.2016
- Promoted, developed, and enhanced two hospital oncology programs as a Nurse Navigator to serve and support /educate patients and physicians. Assisted in implementing multidisciplinary clinics to provide efficient health care in a focused oncology setting.
- Gathered data for all oncology patients for registration in the national database for hospital compliance and national oncology certification measures to meet designated metrics.
- Evaluated and educated potential candidates for various clinical trials. Shown vast and in-depth knowledge of the clinical trial process.
- Participated as a senior Clinical Operations Oncology Committee member, Tumor Boards, and Clinical Correlation Committee member.
- Established a rapport with various cultural and diverse populations and has shown the ability to work autonomously and within a multi-disciplinary team and effectively communicate verbally and in the written context with other health care professionals and clinicians.
- Emory St. Joseph’s Hospital
Oncology Specialist
Visiting Nurse Health Systems/Hospice Atlanta
04.2010 - 10.2014
- Possess competent and knowledgeable assessment skills for determining eligibility and acuity for clinical, psychiatric, and long-term acute care facilities and navigating and educating services deemed appropriate for patients’ needs. (70%-85% oncology patients)
- Interfaced/Consulted with HCPs, and KOLs for end-of-life, palliative, and prognostic treatment plans.
- Graduate educated and trained in counseling, specializing in grief and bereavement for interaction, education, and support for patients and caregivers electing end-of-life treatment.
- Gentiva Health Services/Hospice (Oncology Specialist)
- Accenture/Guardian Hospice
- HCR Manorcare/Heartland Hospice
- Clinical Nurse Liaison and Educator/Case Manager for three Emory Hospitals and The Winship Institute; Grady Memorial and Atlanta Medical Center
Education
Baccalaureate of Science in Nursing -
Kennesaw State University
Master’s Degree - Behavioral Health
Argosy University
Nationally Certified Paralegal - Litigation
National Center for Paralegal Training
Bachelor of Arts - Behavioral Health
University of Georgia
Skills
- Oncology Nurse Educator/Medical Science Liaison/Clinical Science Liaison
- Oncology Nurse Navigator
- Certified Oncology Abstractor
- Good Clinical Practice Certified
- Oncology/Hematology/Renal Nurse/Level 1 Trauma
- National and Area Liaison/Educator for Clinical Treatment Programs/Hospice
- Proven Sales/Marketing and Business Development in clinical settings
- Oncology Clinical Trials/Researcher
- Senior Litigation Paralegal/Nurse Legal Consultant
- Senior Project Management/Healthcare Specialization Consultant
- National Mentor for diagnosed breast cancer patients and breast cancer survivors
- Oncology facilitator/moderator delivering healthcare innovations to the commercial market and with nursing advisory boards Extensive, dedicated research and continuing education hours in various oncology-related courses, with a strong focus on maintaining current updates with ASCO, ESMO, ASH, NCCN, NIH, and other international oncology organizations Numerous participatory CME hours and virtual conference attendance achieved in precision medicine, molecular oncology, biomarker/diagnostic testing, biopsy research, and targeted therapies
- Ability to communicate and advance the scientific platform with medical affairs and the medical community while developing peer-to-peer professional relationships with scientific and medical leads
- Scholarship recipient for Board Certification Medical Specialist Program (BCMAS)
- Recognized as a Top Nurse by the International Nurses’ Association; Recipient of Strathmore’s Who’s Who Worldwide Recognition within the nursing field
Additional Training and Course Work
Attendance at Precision Medicine Leaders Summit, “Precision Oncology and Diagnostics in Precision Medicine,” Chicago, IL October 19-20, 2022; Concepts and Recent Advances in Oncology; Corticosteroids and Implication of Long Term Immunosuppression; Frankly Speaking: Clinical Trials; Beyond Guidelines: Clinical Investigators; Cancer Survivorship; Biomarkers: The Foundation of Personalized Oncology; Glycoserve Symposium 2022; 8th Annual Immuno-Oncology Innovation Forum; The Modern Approach to Data Management in Oncology Trials; Oncology Immunotherapy Global Virtual Conference; Oncology Sneak Preview Exclusive Insights on Upcoming Data and Developments (Medscape/LinkedIn); What’s the Formula? Breaking the Rules of Science in Oncology (AbbVie); 7th International Webinar on Breast Cancer and Woman’s Health; 1st International Basic Oncology Congress; Translational Glycobiology Seminar: Genetic Approach to Glycomics and Cancer Glycome; Presence and Presentation Skills; The Role of Companion Diagnostics in Oncology Care; Targeting NSCLC with EGRF Exon 20 insertions (Clinical Care Solutions); Assessing Immune Cell Function, Metabolic Fitness and Persistence (Agilent); Comprehensive Molecular Tumor Analysis Integrating RNA Sequencing and tumor Immune Environment for Targeted Therapy (Qiagen); Next Generation of Cellular Therapies: A Blueprint to Accelerate Development (Friends of Cancer Research); Advocate Chat: Genetic Testing and Underserved Communities; Participation in the Alamo Breast Cancer Foundation Advocate Program (San Antonio Breast Cancer Symposium); National Breast Cancer Coalition; Clinical Application of Advances in Metastatic Prostate Cancer: Education and Resources for Nurses; Precision Oncology and Diagnostics In Precision Medicine; Impact of Multimodal Algorithms on Patient Diagnosis, Prognosis, and Clinical Trial Matching; Writing the Future of Precision Medicine in Cell Therapy; Disparities in Biomarker Testing in Cancer Care- How We Promote an Equitable Benefit?; Developing Companion Diagnostic For Cell Therapies; Precision Oncology Diagnostic Testing for Hematologic Malignancies; Liquid Biopsy for Cancer Detection: Can We Afford to Adopt These Tests? Can We Afford Not To?; The Evolution of Molecular Diagnostics in Cancer; Targeted Therapy in Cancer Driven Lung Cancer; Current Challenges and Challenges; Challenges in Implementation of Personalized Medicine; Latest Advances in How to Use Tissue and Liquid Biopsy in Drug Development; How to Navigate the Development of RNA Expression-based Companion Diagnostics; Population Genetic Screening Efforts in Primary Care; A Dynamic Duo: the Clinical and Financial Benefits of Preventive Oncology; Reducing time to Treatment Initiation in Precision Oncology: the Impact of Fast NGS Testing; Systemic Sample and Real World Data Access Via Markets and Consent Accelerate Precision Testing/Oncology; Addressing Barriers to Precision Medicine and Biomarker Testing; Precision Targeting of Cancer with CRISPR; Unraveling Therapeutic Resistance Mechanisms in Precision Oncology (Agilent).
Languages
English
Timeline
Clinical Oncology Abstractor
Flatiron Health, Inc.
02.2023 - 09.2024
Clinical Science Liaison (CSL)
InterVenn Biosciences
01.2022 - 06.2022
Oncology Nurse Educator, Keytruda (pembrolizumab) Immunotherapy
McKesson/Merck
08.2019 - 07.2021
Clinical Nurse Educator (BD Vascular Devices)
Novasyte, LLC
10.2018 - 09.2019
Associate Content Editor (Lung Cancer)
American Cancer Society
07.2018 - 02.2019
Oncology Nurse Educator/Medical Sciences Liaison
Heron Therapeutics
06.2017 - 01.2018
Clinical Oncology/Scientific Exchange Analyst
Axess Oncology
05.2016 - 10.2016
Oncology Clinical Abstractor
Independent Healthcare Consultant/Oncology Clinical Abstractor
11.2015 - Current
Oncology Nurse Navigator/Educator (GI/GU, Prostate and Solid, and hematologic tumors)
Wellstar North Fulton Hospital
02.2014 - 03.2016
Oncology Specialist
Visiting Nurse Health Systems/Hospice Atlanta
04.2010 - 10.2014
Master’s Degree - Behavioral Health
Argosy University
Nationally Certified Paralegal - Litigation
National Center for Paralegal Training
Bachelor of Arts - Behavioral Health
University of Georgia
Baccalaureate of Science in Nursing -
Kennesaw State University